Affordability


A promotional image for the the KFF Health Policy 101 Health Care Costs and Affordability chapter

Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. The Health Care Costs and Affordability chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies across the population, the impact of costs on care affordability and individuals' overall financial vulnerability.

 View the Chapter →


Filter

151-160 of 437 results

  • JAMA Forum: Surprise, Surprise

    Perspective

    Larry Levitt's February 2016 post explains how "surprise medical bills" -- unanticipated charges for out-of-network care - can happen. It describes some government approaches to the issue and outlines the challenges to protecting consumers. The post is now available at The JAMA Forum.

  • Why Affordability Is the Big Tent

    From Drew Altman

    In this column, KFF President and CEO Drew Altman explores why the public's concerns about out-of-pocket health costs make health care affordability the health policy issue most likely to resonate with voters across the political spectrum.

  • Harris is Reframing Health as an Economic Issue

    From Drew Altman

    In his latest column, KFF President and CEO Drew Altman describes how Vice President Harris has reframed health as a pocketbook economic issue, which aligns with voters’ concern about health care costs.

  • Health Care Costs: What You Need To Know

    Event Date:
    Event

    On Wednesday, April 1, the Kaiser Family Foundation and the Alliance for Health Reform presented a briefing to explore the trends in health care costs in both the public and private sectors.

  • FAQs on Prescription Drug Importation

    Issue Brief

    These FAQs address questions related to prescription drug importation, including the current status of importation proposals, details of Florida’s importation program recently authorized by the FDA, and concerns and challenges with this approach.